ARTERRA BIOSCIENCE (ARBS.MI)

EUR 2.24

(0.0%)

Operating Income Summary of ARTERRA BIOSCIENCE

ARTERRA BIOSCIENCE's latest annual operating income in 2023 was -1.53 Million EUR , up 190.17% from previous year.
ARTERRA BIOSCIENCE's latest quarterly operating income in 2024 Q2 was 511.19 Thousand EUR , down 0.0% from previous quarter.
ARTERRA BIOSCIENCE reported an annual operating income of 365.02 Thousand EUR in 2022, down -24.49% from previous year.
ARTERRA BIOSCIENCE reported an annual operating income of 483.41 Thousand EUR in 2021, up 422.38% from previous year.
ARTERRA BIOSCIENCE reported a quarterly operating income of 955.37 Thousand EUR for 2023 Q4, down 0.0% from previous quarter.
ARTERRA BIOSCIENCE reported a quarterly operating income of 1.05 Million EUR for 2023 FY, up 190.17% from previous quarter.

Annual Operating Income Chart of ARTERRA BIOSCIENCE (2023 - 2017)

Historical Annual Operating Income of ARTERRA BIOSCIENCE (2023 - 2017)

Year	Operating Income	Operating Income Growth
2023	-1.53 Million EUR	190.17%
2022	365.02 Thousand EUR	-24.49%
2021	483.41 Thousand EUR	422.38%
2020	-149.95 Thousand EUR	-206.29%
2019	141.08 Thousand EUR	-72.35%
2018	510.15 Thousand EUR	31.46%
2017	388.08 Thousand EUR	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	511.19 Thousand EUR	0.0%
2023 Q4	955.37 Thousand EUR	0.0%
2023 FY	1.05 Million EUR	190.17%
2023 Q2	-555.06 Thousand EUR	0.0%
2022 FY	365.02 Thousand EUR	-24.49%
2022 Q2	552.94 Thousand EUR	0.0%
2022 Q4	-193.82 Thousand EUR	0.0%
2021 Q2	-91.76 Thousand EUR	0.0%
2021 FY	483.41 Thousand EUR	422.38%
2021 Q4	423.2 Thousand EUR	0.0%
2020 Q4	-92.86 Thousand EUR	0.0%
2020 Q2	-57.09 Thousand EUR	0.0%
2020 FY	-149.95 Thousand EUR	-206.29%
2019 Q3	297.49 Thousand EUR	-13.69%
2019 FY	141.08 Thousand EUR	-72.35%
2019 Q4	-178.46 Thousand EUR	-159.99%
2019 Q2	344.66 Thousand EUR	0.0%
2018 Q4	433.01 Thousand EUR	0.0%
2018 FY	510.15 Thousand EUR	31.46%
2018 Q2	94.52 Thousand EUR	0.0%
2017 FY	388.08 Thousand EUR	0.0%

Peer Operating Income Comparison of ARTERRA BIOSCIENCE

Name	Operating Income	Operating Income Difference
Philogen S.p.A.	-8.84 Million EUR	82.65%
Ulisse Biomed S.p.A.	-3.45 Million EUR	55.66%